Martin J. Gilligan
Corporate Officer/Principal bij PHATHOM PHARMACEUTICALS, INC.
Actieve functies van Martin J. Gilligan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 06-01-2020 | - |
Loopbaan van Martin J. Gilligan
Eerdere bekende functies van Martin J. Gilligan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CELGENE | Corporate Officer/Principal | - | - |
Opleiding van Martin J. Gilligan
| Providence College | Undergraduate Degree |
| Rutgers State University of New Jersey | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Beurs
- Insiders
- Martin J. Gilligan
- Ervaring
